COVID-19 Spike RBD and Membrane Protein Human IgG ELISA Assay |
MBS412772-48AntigenWells48ControlAntigenWells |
MyBiosource |
48AntigenWells&48ControlAntigenWells |
EUR 635 |
Human IgG antibody Laboratories manufactures the dsred vsv spike protein reagents distributed by Genprice. The Dsred Vsv Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Dsred products are available in stock. Specificity: Dsred Category: Vsv Group: Spike Protein
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human MERS-COV Spike S1 Antibody IgG (MCSS1-IgG) ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Coronavirus (COVID-19 Spike Protein S1) Antibody, Recombinant Human IgG |
MyBiosource |
0.05mg |
EUR 795 |
Coronavirus (COVID-19 Spike Protein S1) Antibody, Recombinant Human IgG |
MyBiosource |
5x0.05mg |
EUR 3370 |
Spike Protein information
Cherry (mCherry, DsRed, Discosoma) |
MBS644071-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2765 |
Cherry (mCherry, DsRed, Discosoma) |
MBS6012446-01mL |
MyBiosource |
0.1(mL |
EUR 575 |
Cherry (mCherry, DsRed, Discosoma) |
MBS6012446-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2440 |
Cherry (mCherry, DsRed, Discosoma) |
MBS6008405-01mL |
MyBiosource |
0.1(mL |
EUR 540 |
Cherry (mCherry, DsRed, Discosoma) |
MBS6008405-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2275 |
Recombinant purified Red Fluorescent Proteins (RFP/dsRed) protein control for Western blot |
RFP12-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Recombinant (E. coli) Red Fluorescent Proteins (RFP/dsRed) protein for ELISA or Standards (>98%) |
RFP15-R |
Alpha Diagnostics |
25 ug |
EUR 300 |
Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
78637-1 |
BPS Bioscience |
100 µl |
EUR 795 |
Description: The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike corresponding to the initial strain (Genbank Accession #QHD43416.1) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6, Calu-3, and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G are preferred for use in cells such as Vero-E6 and Calu-3.The infectivity of VSV-Delta G pseudotypes is restricted to a single round of replication, therefore the pseudotypes can be handled using BSL-2 containment practices. |
Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) |
78637-2 |
BPS Bioscience |
500 µl x 2 |
EUR 3995 |
Description: The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) was produced with SARS-CoV-2 Spike corresponding to the initial strain (Genbank Accession #QHD43416.1) as the envelope glycoprotein instead of VSV-G. The pseudovirions contain the firefly luciferase gene; therefore, the spike-mediated cell entry can be measured via luciferase activity. The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) can be used to measure the activity of a neutralizing antibody against SARS-CoV-2 in a Biosafety Level 2 facility.The Spike (SARS-CoV-2) Pseudotyped VSV Delta G (Luciferase Reporter) has been validated for use with target cells Vero-E6, Calu-3, and ACE2-HEK293 (BPS Bioscience #79951). Spike VSV Delta G are preferred for use in cells such as Vero-E6 and Calu-3.The infectivity of VSV-Delta G pseudotypes is restricted to a single round of replication, therefore the pseudotypes can be handled using BSL-2 containment practices. |
Mouse monoclonal DsRed-Monomer antibody, Clone 4C7 |
E45M08839V-2 |
EnoGene |
50 ul |
EUR 195 |
Mouse Monoclonal DsRed-Monomer Antibody, Clone 4C8 |
E45M08840V-2 |
EnoGene |
50 ul |
EUR 195 |
Mouse monoclonal DsRed-Express2 antibody, Clone 1C4 |
E45M08827V-2 |
EnoGene |
50 ul |
EUR 195 |